论文部分内容阅读
高脂血症是动脉粥样硬化、冠心病及脑卒中的重要危险因素。国内外大量文献报道或研究证实 ,降脂治疗可以减少冠心病事件或脑卒中的发生率。因此 ,降脂治疗日益受到广大医务工作者的普遍关注[1 ] 。 2 0 0 1年 1— 1 1月我院应用吉非罗齐治疗原发性高脂血症 36例 ,旨在观察其调
Hyperlipidemia is an important risk factor of atherosclerosis, coronary heart disease and stroke. A large number of domestic and foreign reports or studies confirmed that lipid-lowering treatment can reduce the incidence of coronary heart disease or stroke. Therefore, lipid-lowering treatment is increasingly widespread concern of the majority of medical workers [1]. January 2011 January-January gemfibrozil treatment of primary hyperlipidemia in 36 cases, to observe the tone